RHEI Pharmaceuticals, Chairman & CEO

Prior to joining RHEI Pharmaceuticals of Plainsboro, NJ, in February 2008 as Chairman and CEO, Dr. Cauwenbergh founded Phases 123 LLC, a company focused on identifying high potential health care technology platforms and emerging health care companies. Read more »

BioNJ, President

Debbie Hart serves as the President of BioNJ. She worked alongside New Jersey’s leading biotechnology industry CEOs to establish BioNJ in 1994. Read more »

Dr. Drakeman formerly served, since inception, as President and CEO of Genmab, the creator and developer of Arzerra™, a novel cancer therapy recently approved in the US and Europe for patients with  the most common form of leukemia who have exhausted their treatment options. Read more »

Celgene Corporation, Chairman and CEO

Sol J. Barer, Ph.D. has been CEO of Celgene since May 1, 2006 and Chairman since January 1, 2007. Read more »

Celldex Therapeutics, President and CEO

Anthony Marucci was a founder of Celldex and served as Vice President, Chief Financial Officer, Treasurer and Secretary from May 2003 until his appointments as Executive Vice President in March 2008, President and Chief Executive Officer in October 2008 and to the Board of Directors in December 2008. Read more »